Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy.
Several immunosuppressive treatments have demonstrated their efficacy in idiopathic membranous nephropathy, but spontaneous remission does develop in more than 30% of patients. The availability of a validated biomarker that is easy to measure and able to accurately predict long-term outcomes would be very helpful for tailoring treatment of the disease to the individual.
Nephrology Division, Hospital 12 de Octubre, Avenida de Córdoba s/n, 28041 Madrid, Spain. mpragat@senefro.org
Manuel
M
Praga
Jorge
J
Rojas-Rivera
D015415:Biomarkers / Q000032:analysis; D015331:Cohort Studies; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood*; D018450:Disease Progression; D005260:Female; D005919:Glomerular Filtration Rate; D015433:Glomerulonephritis, Membranous / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D011507:Proteinuria / Q000503:physiopathology*; D012075:Remission, Spontaneous; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D013030:Spain
D015415:Biomarkers; D007166:Immunosuppressive Agents; D003404:Creatinine